Featured Research

from universities, journals, and other organizations

Thyroid medication has no effect on death rates in patients with subclinical hypothyroidism

Date:
May 4, 2014
Source:
European Society of Endocrinology
Summary:
Treating subclinical hypothyroidism with levothyroxine has no effect on overall mortality rates, according to research. Subclinical hypothyroidism is a mild form of underactive thyroid disease where patients have raised levels of thyroid stimulating hormone (TSH) but a normal concentration of free thyroid hormone. This condition is associated with certain risk factors for increased mortality such as high blood pressure and high cholesterol.

Treating subclinical hypothyroidism with levothyroxine has no effect on overall mortality rates, according to research presented today at the European Congress of Endocrinology in Wrocław, Poland.

Subclinical hypothyroidism is a mild form of underactive thyroid disease where patients have raised levels of thyroid stimulating hormone (TSH) but a normal concentration of free thyroid hormone. This condition is associated with certain risk factors for increased mortality such as high blood pressure and high cholesterol. There is some debate within the medical community on whether it is effective to treat these patients with a medication called levothyroxine, which increases thyroid hormone levels. Although this treatment is generally well-tolerated, a number of side-effects can occur if thyroid hormone levels are raised too much.

Researchers from Gentofte University Hospital in Denmark examined the medical records of 628,953 patients who had received thyroid function tests from 2000-2009. 12,212 (1.9%) patients were diagnosed with subclinical hypothyroidism. Of these, 2,483 patients (20.3%) were prescribed levothyroxine within the first six months. The remaining 9,729 patients (79.7%) either started levothyroxine therapy later than six months after their initial blood test, or did not receive any substitution treatment.

Patients were then followed for a mean time of five years. During follow up, 1,566 of the subclinical hypothyroidism patients died. There was no significant difference in mortality rates between patients who received levothyroxine treatment and those who did not.

Research Fellow, Mette Andersen, who led the study, said, "This is the largest population-based study to examine whether levothyroxine treatment for patients with subclinical hypothyroidism can affect their mortality. Using readily-available registry data, we were able to examine a large population and compare treated versus untreated subclinical hypothyroidism patients with respect to all-cause mortality."

"Our main finding was that levothyroxine treatment had no effect on overall death rates in subclinical hypothyroidism patients. Although previous studies have indicated that levothyroxine treatment may improve some markers of heart function, we found no evidence that this translates into increased survival for these patients."

"Any patients who are worried about their treatment should visit their doctor to discuss their concerns," concluded Andersen.

The team now plan to examine the effect of levothyroxine medication on a subset of subclinical hypothyroidism patients who also have heart conditions in more detail.


Story Source:

The above story is based on materials provided by European Society of Endocrinology. Note: Materials may be edited for content and length.


Cite This Page:

European Society of Endocrinology. "Thyroid medication has no effect on death rates in patients with subclinical hypothyroidism." ScienceDaily. ScienceDaily, 4 May 2014. <www.sciencedaily.com/releases/2014/05/140504095318.htm>.
European Society of Endocrinology. (2014, May 4). Thyroid medication has no effect on death rates in patients with subclinical hypothyroidism. ScienceDaily. Retrieved July 30, 2014 from www.sciencedaily.com/releases/2014/05/140504095318.htm
European Society of Endocrinology. "Thyroid medication has no effect on death rates in patients with subclinical hypothyroidism." ScienceDaily. www.sciencedaily.com/releases/2014/05/140504095318.htm (accessed July 30, 2014).

Share This




More Health & Medicine News

Wednesday, July 30, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Generics Eat Into Pfizer's Sales

Generics Eat Into Pfizer's Sales

Reuters - Business Video Online (July 29, 2014) Pfizer, the world's largest drug maker, cut full-year revenue forecasts because generics could cut into sales of its anti-arthritis drug, Celebrex. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
Nigeria Ups Ebola Stakes on 1st Death

Nigeria Ups Ebola Stakes on 1st Death

Reuters - Business Video Online (July 29, 2014) Nigerian authorities have shut and quarantined a Lagos hospital where a Liberian man died of the Ebola virus, the first recorded case of the highly-infectious disease in Africa's most populous economy. David Pollard reports Video provided by Reuters
Powered by NewsLook.com
Running 5 Minutes A Day Might Add Years To Your Life

Running 5 Minutes A Day Might Add Years To Your Life

Newsy (July 29, 2014) According to a new study, just five minutes of running or jogging a day could add years to your life. Video provided by Newsy
Powered by NewsLook.com
Ebola Outbreak Poses Little Threat To U.S.: CDC

Ebola Outbreak Poses Little Threat To U.S.: CDC

Newsy (July 29, 2014) The Ebola outbreak in West Africa poses little threat to Americans, according to officials with the Centers for Disease Control and Prevention. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins